On this page

CMS RVU26D · Effective 2026-10-01

G0452 Molecular interpretation Medicare reimbursement rates in Oklahoma

Reports a physician’s interpretation of molecular pathology test results, separately from or as part of the global diagnostic service. Compare G0452 office and facility rates across CMS payment localities in Oklahoma.

Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.

What does Medicare pay for G0452 in Oklahoma?

Oklahoma has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.

Office / nonfacility

$44.93

1 of 1 localities have a supported rate.

Payment area: Oklahoma

One mapped payment locality.

Facility setting

No supported rate

These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.

Find G0452 in your payment locality →

Molecular pathology

About G0452: Molecular pathology interpretation and report

Reports a physician’s interpretation of molecular pathology test results, separately from or as part of the global diagnostic service.

A physician reviews results from a molecular pathology assay and prepares an interpretation and report. The testing may analyze DNA or RNA from sources such as tumor tissue or blood to identify molecular findings relevant to diagnosis or treatment. A pathologist or another qualified physician may provide this service in a hospital, reference laboratory, or other setting where molecular diagnostic testing is performed.

Report G0452 for the physician’s interpretive service when supported by the work documented; the assay itself is represented by its applicable test code. CMS recognizes professional and technical components: modifier 26 identifies the interpretation, and modifier TC identifies the technical work, including equipment and staff. Without either modifier, the claim represents the global service. Documentation should identify the test results reviewed and include the physician’s interpretive findings and report. The CMS file lists modifiers 26 and TC as separately priced.

CMS billing rules for G0452

Professional and technical components
Diagnostic test with a professional component (modifier 26, interpretation) and a technical component (modifier TC, equipment and staff); billing without a modifier is the global service.

Where the value comes from

  • Work RVU0.91 · 65%
  • Practice expense (office) RVU0.47 · 34%
  • Malpractice RVU0.02 · 1%

163.3K

Medicare services in 2024 · #428 by national volume

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

G0452 compared with similar codes

Office rates for Oklahoma, from the same CMS release.

81455

So/hl 51/>gsap dna/dna&rna

No office rate

81455 identifies a targeted genomic sequencing panel for specified neoplasm types; G0452 reports the physician’s interpretation and report of molecular results.

81479

Unlisted molecular pathology

No office rate

81479 represents an unlisted molecular pathology procedure when the assay lacks a specific code. G0452 represents interpretive work, not the assay procedure.

81450

Hl neo gsap 5-50dna/dna&rna

No office rate

81450 identifies genomic sequencing for hematolymphoid neoplasms. G0452 describes the physician’s interpretation and report rather than the sequencing assay.

Compare G0452 by payment locality

Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.

1 of 1 payment localities

Office and facility base rates · shared scale starting at $0

Need rates for a whole code list?

Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.

Explore fee-sheet early access →

How this local rate is calculated

Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for G0452 in Oklahoma.

PPRRVU2026_Oct_nonQPP.csv

15,270

Code
G0452
Physician work
0.91
Practice expense
0.47
Malpractice
0.02

GPCI2026.csv

86

Locality
Oklahoma
Physician work
1.000
Practice expense
0.893
Malpractice
0.777
Office / nonfacility calculation for G0452 in Oklahoma
ComponentRVULocality factorAdjusted
Physician work0.91× 1.0000.9100
Practice expense0.47× 0.8930.4197
Malpractice0.02× 0.7770.0155
Total RVUs1.3453
Conversion factor× 33.4009

Office / nonfacility rate, Oklahoma$44.93

Values as parsed from CMS release RVU26D, effective 2026-10-01. The amount is rounded to the nearest cent only at the end.
Explore RVUs, geographic factors and the full formula

Office / nonfacility

Office / nonfacility calculation inputs
ComponentRVULocal GPCI
Work0.911
Practice expense0.470.893
Malpractice0.020.777

(0.91 × 1 + 0.47 × 0.893 + 0.02 × 0.777) × $33.4009 = $44.93

The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.

G0452 billing questions

When should G0452 be reported instead of the molecular assay code?

G0452 represents the physician’s interpretation and report, not the laboratory procedure that generates the molecular results. Report the applicable assay code for the testing itself.

How do modifiers 26 and TC affect G0452?

Modifier 26 reports the professional interpretation, while modifier TC reports the technical work, including equipment and staff. Without a modifier, G0452 represents the global service.

What documentation supports G0452?

Document the molecular test results reviewed and the physician’s interpretation and report. The record should make clear that the reported service includes interpretive work, not only test performance.

Can G0452 be reported with a molecular assay code?

Yes, the interpretation may be reported with the applicable molecular assay code when both the test and the physician’s interpretive service are furnished and documented.

Does G0452 describe a particular gene panel or specimen?

No. G0452 identifies the interpretation and report service; the assay code identifies the specific molecular test and its scope.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.

Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.

RVUs for G0452PPRRVU2026_Oct_nonQPP.csv, line 15,270 (RVU26D)
Geographic factors for OklahomaGPCI2026.csv, line 86 (RVU26D)